Revolutionizing tissue regeneration for a healthier future
Chronic diseases, such as liver failure, present significant challenges due to limited treatment options and the scarcity of donor organs. Traditional therapies often fail to provide long-term solutions, leading to prolonged patient suffering and increased healthcare burdens. For instance, liver transplants remain the primary treatment for end-stage liver disease, but donor shortages and high costs make this option inaccessible to many patients. There is a pressing need for innovative therapies that can effectively restore organ function and improve patient outcomes.
What is the Solution?
ClexBio is pioneering the development of bioengineered tissues that closely mimic human biology, offering new possibilities for regenerative medicine. Their proprietary platform combines multiple cell types to create complex tissue structures designed to restore organ function. Initially focusing on hepatocyte-based liver tissue products, ClexBio aims to provide viable alternatives to liver transplants, addressing the critical shortage of donor organs and offering hope to patients with end-stage liver disease.
Beyond liver applications, ClexBio’s technology holds promise for treating a wide range of chronic diseases. By developing scalable, off-the-shelf tissue therapies, they seek to transform the therapeutic landscape, making advanced treatments more accessible and affordable. Their innovative approach not only addresses current medical needs but also sets the stage for future advancements in tissue engineering and regenerative medicine.
ClexBio is a part of EQT Foundation’s Portfolio.
What EQT Foundation loves about ClexBio
ClexBio is breathing new life into the future of medicine—quite literally. By creating bioengineered tissues that mimic human biology, they’re proving that when it comes to chronic diseases, innovation can outperform limitations. We love how ClexBio is taking the phrase “think outside the box” to heart, crafting solutions that not only restore organ function but also restore hope for countless patients. It’s a step toward a world where no one has to wait for a second chance at life.
ThinQ is the must-bookmark publication for the thinking investor.
More from Library of Hope
Do You Want to Know More?
Get in touch with us and take the first step to successive growth.
Get the Latest Updates
Subscribe to EQT Foundation's press releases and updates.